Drugs / SWE
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05035680 | Jul 2022 → Mar 2023 | influenza | Gates Medical Research Institute | Withdrawn | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SWE | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05035680 ↗ |
| Modality | Other / unclassified | “SWE adjuvant mixed with unadjuvanted seasonal influenza vaccine shortly before dosing (SWE + QIV)” NCT05035680 ↗ |
| Route | Intramuscular | “Single 0.8 mL IM injection” NCT05035680 ↗ |